Paper Details

  1. Home
  2. Paper Details

Leukotriene receptor antagonists for eczema.

Author: FergusonLeila, FutamuraMasaki, KojimaReiji, MoriRintaro, RobertsAmanda, SasakiHatoko, VakirlisEfstratios

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Eczema is a common and chronic skin condition often associated with allergies, including asthma. While medications that block leukotrienes (LTRAs) are used to reduce the need for steroids in asthma, their role in eczema is still unclear. Current treatments for eczema often cause side effects, and stronger medications have limitations. This highlights the need for new treatments for eczema.
Paper Details　
Original Abstract of the Article :
Eczema is a common, chronic, inflammatory skin condition that is frequently associated with atopic conditions, including asthma. Leukotriene receptor antagonists (LTRAs) have a corticosteroid-sparing role in asthma, but their role in eczema remains controversial. Currently available topical therapie...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517006/

データ提供：米国国立医学図書館（NLM）

A New Frontier in Eczema Treatment

Eczema, a chronic skin condition, can be a frustrating and persistent problem. It's like a persistent sandstorm that irritates the skin and makes it difficult to find relief. This study explores the potential role of leukotriene receptor antagonists (LTRAs) in treating eczema, which are commonly used for asthma but their effect on eczema is still under debate.

A Promising Oasis in the Desert of Eczema

The study suggests that LTRAs may offer a corticosteroid-sparing role in managing eczema. It's like finding a new type of oasis in the desert, offering a potential alternative to traditional treatment. LTRAs may help reduce the need for topical corticosteroids, which can have side effects.

Finding a Sustainable Solution

This research opens up new avenues for treating eczema, but more research is needed to fully understand the role of LTRAs. It's like a new path in the desert, offering potential for a more sustainable solution. It's important to continue researching alternative and complementary therapies to manage eczema and improve the lives of those affected by it.

Dr. Camel's Conclusion

This research offers a glimmer of hope in the desert of eczema, reminding us that there is always room for new discoveries. It emphasizes the importance of exploring new avenues for treatment and finding the most effective solutions for individual patients.

Date :
  1. Date Completed 2019-02-01
  2. Date Revised 2022-08-30
Further Info :

Pubmed ID

30343498

DOI: Digital Object Identifier

PMC6517006

Related Literature

Article Analysis
・Effective treatment of eczema
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.